Publications

5674 Results

Evaluation of CSF1R as a Prognostic and Predictive Biomarker in Colorectal Cancer

Authors
S Algaze;Y Yang;J Millstein;F Battaglin;S Soni;S Soni;P Mittal;K Ashouri;P Jayachandran;H Arai;L Torres Gonzalez;W Zhang;H-J Lenz
Journal / Conference
ASCO GI Cancers Symposium (January 23-25, 2025, San Francisco, CA)
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Lessons Learned from SWOG S1316: Optimizing Surgical Trial Design for Malignant Bowel Obstruction

Authors
M Farooq;N Amini;G Anderson;V Sun;G Deutsch;J Deneve;M Grant;R Krouse
Journal / Conference
Society for Surgical Oncology Annual Meeting (March 27-29, 2025, Tampa, FL)
Year
2025
Research Committee(s)
Palliative Care
Study Number(s)
S1316

Post hoc analysis of S9346 data

Authors
A Sokolova;C Tangen;M Hussain;C Sweeney;T Dorff;I Thompson;S Lerner
Journal / Conference
ASCO GU Cancers Symposium (Feb 13-15, 2025, San Francisco, CA)
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Effect of baseline geriatric and quality of life assessments on treatment outcomes in ECOG-ACRIN EA2186 (GIANT) - A randomized phase II study of Gemcitabine and NabPaclitaxel compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (NCT04233866)

Authors
E Dotan;P Catalano;L Lenchik;R Boutin;X Yao;J Ohr;K Lim;G Fisher;N Vijayvergia;S Chandana;A Kalyan;R Dunne;D Zhen;D Li;K Reiss;M Simon;J Berlin;L Waggoner;P O'Dwyer
Journal / Conference
ASCO GI Cancers Symposium (January 23-25, 2025, San Francisco, CA)
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/EA2186

Efficacy and Safety of Cabozantinib for Advanced Gastrointestinal Neuroendocrine Tumors (NET) after Progression on Prior Therapy: A Subgroup Analysis of the Phase III CABINET Trial (Alliance A021602)

Authors
J Strosberg;T Zemla;S Geyer;M Knopp;S Behr;S Pulsipher;J Acoba;A Shergill;E Wolin;T Halfdanarson;B Konda;N Trikalinos;B Tawfik;N Raj;S Shaheen;N Vijayvergia;A Dasari;E O'Reilly;J Meyerhardt;J Chan
Journal / Conference
ASCO GI Cancers Symposium (January 23-25, 2025, San Francisco, CA), abstract 666
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021602

Approach to Treatment of Metastatic Hormone Sensitive Prostate (mHSPC) Cancer Among Cooperative Oncology Groups in North America

Authors
C Chalker;M Ong;R McKay;S Gulati;C Tangen;S Lerner;T Dorff;A Sokolova
Journal / Conference
ASCO GU Cancers Symposium (Feb 13-15, 2025, San Francisco, CA), poster
Year
2025
Research Committee(s)
Genitourinary

A phase III randomized trial of eribulin (E) with gemcitabine vs standard of care (SOC) for patients (pts) with metastatic urothelial carcinoma (mUC) refractory to or ineligible for PD/PDL1 antibody (Ab): SWOG S1937- Updated Design

Authors
S Sadeghi;M Plets;P Lara;C Tangen;S Berg;J Brown;R Bangs;D Nakagawa;S Daneshmand;I Thompson;T Flaig;D Petrylak;S Lerner
Journal / Conference
ASCO GU Cancers Symposium (Feb 13-15, 2025, San Francisco, CA), Trials in Progress, TPS887
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
S1937

Secondary analysis of SWOG S1316 shows improved survival with surgical intervention for malignant bowel obstruction

Authors
J Lee;R Krouse
Journal / Conference
Society for Surgical Oncology Annual Meeting (March 27-29, 2025, Tampa, FL)
Year
2025
Research Committee(s)
Palliative Care
Study Number(s)
S1316

Presence of Ascites in the Setting of Malignant Bowel Obstruction Leads to Shorter Survival

Authors
K Dougherty;J Lee;J Deneve
Journal / Conference
Society for Surgical Oncology Annual Meeting (March 27-29, 2025, Tampa, FL)
Year
2025
Research Committee(s)
Palliative Care
Study Number(s)
S1316

Evaluating survival post-7 mo PSA response, stratified by response, disease extent, and intermittent vs. continuous ADT in mHSPC: The S9346 trial

Authors
A Sokolova;C Tangen;M Hussain;C Sweeney;T Dorff;I Thompson;S Lerner
Journal / Conference
ASCO GU Cancers Symposium (Feb 13-15, 2025, San Francisco, CA), poster, abstract 268
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346